$0.45 0.1 12.5%
Last Trade - 4:19pm
| Market Cap | £11.0m |
| Enterprise Value | £11.0m |
| Revenue | £n/a |
| Position in Universe | th / 6647 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Nov | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.006 | 6.41 | 8.60 | 0.000 | 0.000 | 0.000 | -100.0% | ||||
| -12.7 | ||||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Biolife Sciences Inc., formerly Rhino Novi Inc., is a commercialization accelerator, licensor and developer of technology for the healthcare, beauty and food, material science and beverage industry sector. The Company’s core business develops, licenses and distributes antimicrobial products, non-contract human temperature screening technology and touchless vending products. Its technology solutions include BioLife Eco-Safe Surface Sanitizer, which is a botanically-derived disinfectant that kills bacteria, fungi and viruses; Antimicrobial Copper Air Filters cleans the air and releases copper ions to protect against bacteria and germs found circulating in enclosed rooms and buildings and BioLife Intelligent Touchless Vending and Marketplaces that provides digital advertising and digital vending machines serving a wide range of personal protective equipment and antimicrobial products. Its non-contract human temperature screening technology solutions detects subjects’ body temperature.
| Last Annual | November 30th, 2012 |
| Last Interim | November 30th, 2012 |
| Incorporated | March 31, 2000 |
| Public Since | April 25, 2005 |
| No. of Shareholders: | n/a |
| No. of Employees: | 565 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 38,038,486 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 67 Wall St, NEW YORK, 10005-3101, United States |
| Web | |
| Phone | +1 702 8662500 |
| Auditors | John Scrudato CPA |
As of 4:19pm, shares in Biolife Sciences Inc are trading at $0.45, giving the company a market capitalisation of £11.0m. This share price information is delayed by 15 minutes.
Shares in Biolife Sciences Inc are currently trading at $0.45 and the price has moved by 0.271k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biolife Sciences Inc price has moved by 0.192k% over the past year.
There are no analysts currently covering Biolife Sciences Inc.
Biolife Sciences Inc is scheduled to issue upcoming financial results on the following dates:
Biolife Sciences Inc does not currently pay a dividend.
Biolife Sciences Inc does not currently pay a dividend.
Biolife Sciences Inc does not currently pay a dividend.
To buy shares in Biolife Sciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Biolife Sciences Inc are currently trading at $0.45, giving the company a market capitalisation of £11.0m.
Here are the trading details for Biolife Sciences Inc:
We were not able to load our ranking data for Biolife Sciences Inc
We were not able to load any forecast data for Biolife Sciences Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biolife Sciences Inc. Over the past six months, the relative strength of its shares against the market has been -73.7%. At the current price of $0.45, shares in Biolife Sciences Inc are trading at -64.68% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Biolife Sciences Inc.
Biolife Sciences Inc's management team is headed by:
Here are the top five shareholders of Biolife Sciences Inc based on the size of their shareholding:
